Completed OBSERVATIONAL NCT03614637

Cannabis Use and Epigenetic Alterations in Human Male Sperm Cells

Cannabis Use and Epigenetic Alterations in Human Male Sperm Cells: Effects of Exposure and Abstinence (Component 1)

Sponsor: Duke University

Interventions Cannabis use abstinence for 11 weeks

Updated 8 times since 2018 Last updated: Jul 2, 2020 Started: Nov 7, 2017 Primary completion: Mar 16, 2020 Completion: Mar 16, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Cannabis Use and is currently completed. Duke University leads this study, which shows 8 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Aug 2020 — Jan 2021 [monthly]

Completed

Status: Recruiting → Completed
Mar 2020 — Aug 2020 [monthly]

Recruiting

▶ Show 3 earlier versions

Dec 2019 — Mar 2020 [monthly]

Recruiting
Jan 2019 — Dec 2019 [monthly]

Recruiting
Sep 2018 — Jan 2019 [monthly]

Recruiting

First recorded

Nov 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Duke University
John Templeton Foundation

Data source: Duke University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Durham, United States